Banque de Luxembourg’s AbbVie ABBV Stock Holding History

Banque de Luxembourg’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196K	Hold	777	–	–	0.09%	54
2026 Q1	$169K	Sell	777 -5	-0.6%	-$1.11K	0.09%	57
2025 Q4	$179K	Buy	782 +128	+20%	+$29.2K	0.08%	62
2025 Q3	$151K	Sell	654 -123	-16%	-$25K	0.08%	55
2025 Q2	$163K	Hold	777	–	–	0.09%	55
2025 Q1	$163K	Hold	777	–	–	0.09%	55
2024 Q4	$139K	Buy	+777	New	+$143K	0.07%	59

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Banque de Luxembourg's ABBV Position: Q2 2026 in Review

Banque de Luxembourg held its AbbVie (ABBV) position steady in Q2 2026 at 777 shares worth $196K. The position accounts for 0.09% of the portfolio, ranked #54.

Banque de Luxembourg first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Banque de Luxembourg held 777 shares of AbbVie worth $196K as of Q2 2026.
Banque de Luxembourg left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of Banque de Luxembourg's portfolio in Q2 2026, its #54 holding.
Banque de Luxembourg first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Banque de Luxembourg's 13F filing for Q2 2026, filed 9 Jul 2026.